Skip to main content
. 2018 Jan 17;13(1):e0191522. doi: 10.1371/journal.pone.0191522

Fig 1. Bactericidal activity of PAAG against seventeen MRSA clinical isolates.

Fig 1

PAAG at a concentration of 100 μg/mL was added at timepoint 0 and monitored until 24h. Six log reductions in CFU/mL were observed in 58% of the MRSA isolates tested in 1-4h of treatment. 88% of the MRSA strains was observed within 12h of PAAG treatment. Data is presented as mean ± SD (n = 3).